| CGNAX | FGGIX | CGNAX / FGGIX | |
| Total Expense Ratio | 0.68 | 0.43 | 158% |
| Annual Report Gross Expense Ratio | 0.68 | 0.43 | 158% |
| Fund Existence | 14 years | 5 years | - |
| Gain YTD | 1.975 | 1.974 | 100% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.9B | 21.9B | 100% |
| Annual Yield % from dividends | 1.63 | 1.85 | 88% |
| Returns for 1 year | 11.97 | 12.23 | 98% |
| Returns for 3 years | 43.31 | 44.38 | 98% |
| Returns for 5 years | 32.78 | 34.44 | 95% |
| Returns for 10 years | 115.55 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XUDV | 28.62 | 0.22 | +0.78% |
| Franklin U.S. Dividend Mltplr Idx ETF | |||
| UUP | 27.01 | 0.09 | +0.33% |
| Invesco DB US Dollar Bullish | |||
| DVUT | 25.25 | N/A | N/A |
| WEBs Utilities XLU Defined VolETF | |||
| SPIP | 26.00 | -0.05 | -0.19% |
| State Street® SPDR® Portfolio TIPS ETF | |||
| BBC | 40.97 | -1.23 | -2.91% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||